{"filing":{"accession_number":"0000950103-26-009441","cik":"0001356090","ticker":"PGEN","company_name":"PRECIGEN, INC.","form":"8-K","filing_date":"2026-06-24","report_date":null,"primary_document":"dp248898_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010326009441/dp248898_8k.htm"},"events":[{"id":13497,"run_id":11994,"accession_number":"0000950103-26-009441","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"Stockholders voted at the 2026 Annual Meeting on four proposals: election of nine directors, ratification of Deloitte \u0026 Touche LLP as independent auditor, advisory vote on named executive officer compensation, and approval of an amendment to the 2023 Omnibus Incentive Plan increasing share authorization by 7 million shares. The Item 5.07 disclosure presents tabular voting results (For, Against, Abstain, Broker Non-Votes) for each proposal.","company_name":"PRECIGEN, INC.","ticker":"PGEN","filing_date":"2026-06-24","form":"8-K","submitted_at":null,"items":[{"id":10641,"accession_number":"0000950103-26-009441","item_number":"5.02","item_title":null,"event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure reports stockholder approval of an amendment to the 2023 Omnibus Incentive Plan increasing available shares by 7 million. This is a compensatory arrangement amendment affecting equity grants and incentive awards available to officers and directors, fitting the exec_compensation category. The materiality is high given the substantial increase in share authorization for equity compensation purposes.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-24T20:10:05.795044+00:00","company_name":"","ticker":null,"filing_date":""},{"id":10642,"accession_number":"0000950103-26-009441","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This Item 5.07 disclosure presents the results of the 2026 Annual Meeting of stockholders, including voting outcomes on four proposals: (i) election of nine directors, (ii) ratification of Deloitte \u0026 Touche LLP as independent auditor, (iii) advisory vote on named executive officer compensation, and (iv) approval of an amendment to the 2023 Omnibus Incentive Plan to increase share authorization by 7 million shares. The tabular presentation of vote counts (For, Against, Abstain, Broker Non-Votes) for each proposal is the hallmark of shareholder_vote_results disclosure under Item 5.07.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-24T20:10:05.795044+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":10641,"accession_number":"0000950103-26-009441","item_number":"5.02","item_title":null,"event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure reports stockholder approval of an amendment to the 2023 Omnibus Incentive Plan increasing available shares by 7 million. This is a compensatory arrangement amendment affecting equity grants and incentive awards available to officers and directors, fitting the exec_compensation category. The materiality is high given the substantial increase in share authorization for equity compensation purposes.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-24T20:10:05.795044+00:00","company_name":"PRECIGEN, INC.","ticker":"PGEN","filing_date":"2026-06-24"},{"id":10642,"accession_number":"0000950103-26-009441","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This Item 5.07 disclosure presents the results of the 2026 Annual Meeting of stockholders, including voting outcomes on four proposals: (i) election of nine directors, (ii) ratification of Deloitte \u0026 Touche LLP as independent auditor, (iii) advisory vote on named executive officer compensation, and (iv) approval of an amendment to the 2023 Omnibus Incentive Plan to increase share authorization by 7 million shares. The tabular presentation of vote counts (For, Against, Abstain, Broker Non-Votes) for each proposal is the hallmark of shareholder_vote_results disclosure under Item 5.07.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-24T20:10:05.795044+00:00","company_name":"PRECIGEN, INC.","ticker":"PGEN","filing_date":"2026-06-24"}]}